Company intelligence / Profile preview

Neuraura Biotech

Calgary, Alberta, Canadaneuraura.com ↗

Ownership: Private
Employees: ~5
Development stage: Preclinical

Overview

Neuraura has developed a minimally invasive wearable TENS device ("LoOoP") for PCOS that uses patented micro-electrodes to provide localized electrostimulation. Early results indicate modulation of insulin uptake and metabolic rebalancing. The company also has a brain monitoring platform for epilepsy surgery in prototype/early clinical stages[1][4][5].

Therapeutic areas: EndocrinologyNeurology
Modalities: DeviceBioelectronic therapyDigital health platform
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

LoOoP

Pre-clinical

Indications: Polycystic ovary syndrome

Partnerships

Participation in Canadian Technology Accelerator programacademic collaborations with Hotchkiss Brain Institute and other local institutions

Beyond the preview

Go deeper on Neuraura Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuraura Biotech.

Explore the full profile